Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

How can the public health impact of vaccination be estimated?.
Londono, SE; Li, X; Toor, J; Villiers, MD; Nayagam, S; Hallett, T; Abbas, K; JIT, M; KLEPAC, P; Jean, K; Garske, T; Ferguson, N; Gaythorpe, K;
2021
medRxiv (2021). 10.1101/2021.01.08.21249378.
COVID-19's lost generation of unvaccinated children - Authors' reply.
ABBAS, K; PROCTER, SR; CLARK, A; FLASCHE, S;
2021
The Lancet. Global health, (2021).9 3 10.1016/S2214-109X(20)30537-4.
Evaluating the impact of RSV immunisation strategies on antibiotic use in England.
ATKINS, K; HODGSON, D; JIT, M; DAVIES, N;
2021
medRxiv (2021). 10.1101/2021.11.08.21266072.
Simulation results for "COVID-19 vaccination in Sindh Province, Pakistan: a modelling study of health impact and cost-effectiveness".
PEARSON, CA B; BOZZANI, F; PROCTER, SR; DAVIES, NG; Huda, M; JENSEN, HT; KEOGH-BROWN, M; Khalid, M; SWEENEY, S; TORRES-RUEDA, S; EGGO, RM; VASSALL, A; JIT, M;
2021
, Zenodo (2021).
Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings.
Driciru, E; Koopman, JP R; COSE, S; Siddiqui, AA; Yazdanbakhsh, M; ELLIOTT, AM; Roestenberg, M;
2021
Frontiers in immunology, (2021).12, 10.3389/fimmu.2021.635985.
Correction to: Partnership for Research on Ebola VACcination (PREVAC): protocol of a randomized, double-blind, placebo-controlled phase 2 clinical trial evaluating three vaccine strategies against Ebola in healthy volunteers in four West African countr...
Badio, M; Lhomme, E; Kieh, M; Beavogui, AH; Kennedy, SB; Doumbia, S; Leigh, B; Sow, SO; Diallo, A; Fusco, D; Kirchoff, M; Termote, M; Vatrinet, R; Wentworth, D; Esperou, H; Lane, HC; Pierson, J; WATSON-JONES, D; Roy, C; D'Ortenzio, E; GREENWOOD, B; Chêne, G; Richer, L; Neaton, JD; Yazdanpanah, Y; ... PREVAC study team,
2021
Trials, (2021).22 1 10.1186/s13063-021-05572-3.
Novel vaccine safety issues and areas that would benefit from further research.
Salmon, DA; Lambert, PH; Nohynek, HM; Gee, J; Parashar, UD; Tate, JE; WILDER-SMITH, A; Hartigan-Go, KY; SMITH, PG; Zuber, PL F;
2021
BMJ Glob Health, (2021).6 Suppl 10.1136/bmjgh-2020-003814.
Effect of 4 years of seasonal malaria chemoprevention on the acquisition of antibodies to Plasmodium falciparum antigens in Ouelessebougou, Mali.
Mahamar, A; Issiaka, D; Youssouf, A; Niambele, SM; Soumare, HM; Attaher, O; Barry, A; Narum, DL; Duffy, PE; GREENWOOD, B; Fried, M; Dicko, A;
2021
Malaria journal, (2021).20 1 10.1186/s12936-020-03542-9.
SARS-CoV-2 infection risk during delivery of childhood vaccination campaigns: a modelling study.
PROCTER, S; Abbas, K; FLASCHE, S; Griffiths, U; Hagedorn, B; O'Reilly, K; JIT, M; CMMID COVID-19 Working Group,;
2021
medRxiv (2021). 10.1101/2021.05.14.21257215.
A dose-reduction HPV vaccine immunobridging trial of two HPV vaccines among adolescent girls in Tanzania (the DoRIS trial) - Study protocol for a randomised controlled trial.
BAISLEY, KJ; WHITWORTH, HS; Changalucha, J; Pinto, L; Dillner, J; KAPIGA, S; De Sanjosé, S; MAYAUD, P; HAYES, RJ; Lacey, CJ; WATSON-JONES, D;
2021
Contemporary clinical trials, (2021).101, 10.1016/j.cct.2021.106266.